Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ascendis Pharma AS

ASND
Current price
107.69 USD +0.02 USD (+0.02%)
Last closed 106.5 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 883 725 824 USD
Yield for 12 month -8.01 %
Week
Month
Year
ASND
21.11.2021 - 28.11.2021

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/" for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Address: Tuborg Boulevard 12, Hellerup, Denmark, 2900

Analytics

WallStreet Target Price

0.34 USD

P/E ratio

Dividend Yield

Current Year

+55 711 720 USD

Last Year

+8 467 694 USD

Current Quarter

+52 293 288 USD

Last Quarter

+51 595 449 USD

Current Year

+42 498 503 USD

Last Year

+4 632 301 USD

Current Quarter

+44 250 177 USD

Last Quarter

+37 520 004 USD

Key Figures ASND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -559 929 024 USD
Operating Margin TTM -279.82 %
PE Ratio
Return On Assets TTM -32.98 %
PEG Ratio
Return On Equity TTM -318.41 %
Wall Street Target Price 0.34 USD
Revenue TTM 151 912 000 USD
Book Value -1.3 USD
Revenue Per Share TTM 2.71 USD
Dividend Share
Quarterly Revenue Growth YOY 214.2 %
Dividend Yield
Gross Profit TTM 39 037 000 USD
Earnings Share -11.67 USD
Diluted Eps TTM -11.67 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ASND

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ASND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ASND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 40.236
Price Sales TTM 38.7311
Enterprise Value EBITDA -11.7515
Price Book MRQ 14.5547

Financials ASND

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ASND

For 52 weeks

64.33 USD 127.77 USD
50 Day MA 92.36 USD
Shares Short Prior Month 5 525 238
200 Day MA 93.8 USD
Short Ratio 9.12
Shares Short 4 986 910
Short Percent 12.25 %